San Jose, CA, United States of America

Sekhar Bodupalli

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: J&j Consumer Companies, Inc.. Active years: 2010.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sekhar Bodupalli: Innovator in Dermatological Treatments

Introduction

Sekhar Bodupalli is a notable inventor based in San Jose, California. He has made significant contributions to the field of dermatology through his innovative methods for treating various skin conditions. His work focuses on enhancing the appearance of skin affected by loss of tightness and firmness.

Latest Patents

Sekhar Bodupalli holds a patent for "Methods for treatment of dermatological conditions." This patent describes a method aimed at reducing the appearance of skin conditions associated with loss of skin tightness, skin firmness, or dark circles under the eyes. The method utilizes topical compositions comprising specific compounds as outlined in the patent.

Career Highlights

Sekhar is currently employed at Johnson & Johnson Consumer Companies, Inc., where he continues to develop and refine his innovative approaches to skincare. His expertise in dermatological treatments has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Sekhar has collaborated with esteemed colleagues, including Bing Wang and Xiangfeng Li. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in dermatology.

Conclusion

Sekhar Bodupalli's contributions to dermatological treatments exemplify the impact of innovation in improving skin health. His patent and ongoing work at Johnson & Johnson Consumer Companies, Inc. highlight his commitment to advancing skincare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…